Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

results   symbols : Bmy    save search

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: 0.26% H: 2.03% C: 1.57%
LNTH | $65.19 1.21% 1.2% 580K twitter stocktwits trandingview |
Health Technology
| | O: -0.25% H: 3.58% C: 3.2%

business year therapeutics financial results
Bristol Myers Squibb to Report Results for First Quarter 2024 on April 25, 2024
Published: 2024-03-11 (Crawled : 23:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: 0.2% H: 1.22% C: 0.85%

first report results
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
Published: 2024-02-28 (Crawled : 13:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.91% C: 0.81%

business year update financial results
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Published: 2024-02-06 (Crawled : 21:00) - prnewswire.com
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: -0.14% H: 0.35% C: -1.12%
XNCR | $19.05 3.7% 3.57% 760K twitter stocktwits trandingview |
Health Technology
| | O: -0.05% H: 0.0% C: -2.09%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 1.33% H: 0.0% C: 0.0%
BGNE | $144.0 3.61% 3.48% 220K twitter stocktwits trandingview |
Health Technology
| | O: -3.53% H: 1.53% C: -0.27%
AMGN | News | $273.085 -0.17% -0.17% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.18% H: 0.0% C: -6.22%

year financial results
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
Published: 2024-02-02 (Crawled : 14:30) - biospace.com/
RYZB | $62.49 0.03% 280K twitter stocktwits trandingview |
| | O: 0.03% H: 0.11% C: 0.0%
XYF | News | $3.815 -1.74% 0.39% 5.4K twitter stocktwits trandingview |
Finance
| | O: 1.04% H: 1.79% C: -1.23%
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: 1.23% H: 1.5% C: -1.14%
KRTX | $329.83 0.0% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 0.0% C: 0.0%

financial results
Bristol Myers Squibb to Report Results for Fourth Quarter 2023 on February 2, 2024
Published: 2023-12-15 (Crawled : 22:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: -0.6% H: 0.57% C: -0.53%

report results
Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
Published: 2023-11-06 (Crawled : 15:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: 0.61% H: 0.77% C: -0.66%
MRTX | $58.7 -0.17% 0.34% 0 twitter stocktwits trandingview |
Health Technology
| | O: 0.75% H: 0.59% C: 0.27%

therapeutics financial results
AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS
Published: 2023-10-31 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
| | O: 4.66% H: 0.0% C: -3.51%
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: 0.25% H: 0.54% C: 0.29%
XNCR | $19.05 3.7% 3.57% 760K twitter stocktwits trandingview |
Health Technology
| | O: -0.41% H: 2.1% C: 1.11%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 2.61% H: 0.0% C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.92% C: 0.61%
BGNE | $144.0 3.61% 3.48% 220K twitter stocktwits trandingview |
Health Technology
| | O: 0.14% H: 0.68% C: -0.32%
AMGN | News | $273.085 -0.17% -0.17% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: -2.77% H: 0.6% C: -0.07%

financial results
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
Published: 2023-10-26 (Crawled : 13:00) - biospace.com/
XYF | News | $3.815 -1.74% 0.39% 5.4K twitter stocktwits trandingview |
Finance
| | O: -3.19% H: 4.87% C: 4.87%
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: -4.68% H: 2.46% C: -1.83%
MRTX | $58.7 -0.17% 0.34% 0 twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.47% C: 0.2%

financial results
Samsung Biologics reports third quarter 2023 financial results
Published: 2023-10-25 (Crawled : 07:00) - prnewswire.com
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: -0.18% H: 1.34% C: 1.05%

financial results
Ayala Pharmaceuticals Presents Updated AL102 Results from Phase 2 Clinical Trial in Desmoid Tumors at ESMO Congress 2023
Published: 2023-10-23 (Crawled : 11:00) - globenewswire.com
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: -0.19% H: 0.66% C: -0.62%
ADXS | $0.54 12.48% 950 twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 5.56% C: 0.0%

al102 congress tumors pharmaceuticals trial results phase 2
Bristol Myers Squibb to Report Results for Third Quarter 2023 on October 26, 2023
Published: 2023-09-26 (Crawled : 13:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 0.65% C: -0.56%

report results
SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2023 Financial Results
Published: 2023-08-10 (Crawled : 20:00) - globenewswire.com
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: 0.39% H: 0.33% C: -0.49%
SLS | $1.54 -5.52% -5.84% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.64% H: 3.85% C: -0.72%

business life update sciences financial results
Inhibrx Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-08-07 (Crawled : 23:00) - biospace.com/
TSVT | $4.28 -7.56% -8.18% 470K twitter stocktwits trandingview |
| | O: -0.16% H: 0.0% C: -0.33%
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: 0.03% H: 0.41% C: -0.07%
INBX | $34.385 0.75% 0.74% 220K twitter stocktwits trandingview |
Health Technology
| | O: 0.73% H: 0.0% C: -6.89%
BLUE | $0.9274 -4.45% -4.66% 8.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.77% H: 0.0% C: -7.93%

financial results
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
Published: 2023-07-27 (Crawled : 13:00) - biospace.com/
XYF | News | $3.815 -1.74% 0.39% 5.4K twitter stocktwits trandingview |
Finance
| | O: -1.34% H: 1.36% C: 1.36%
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: -3.21% H: 2.51% C: -0.44%

financial results
Bristol Myers Squibb to Report Results for Second Quarter 2023 on July 27, 2023
Published: 2023-06-08 (Crawled : 12:20) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: 0.28% H: 0.42% C: -0.05%

report results
Updated RINGSIDE Phase 2 Results Featured in Poster Discussion Session at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2023-06-05 (Crawled : 12:00) - globenewswire.com
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: 0.37% H: 0.85% C: 0.12%
ADXS | $0.54 12.48% 950 twitter stocktwits trandingview |
Health Technology
| | O: -2.73% H: 4.42% C: -0.4%

meeting results phase 2
Ayala Pharmaceuticals Announces Updated RINGSIDE Phase 2 Results at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2023-05-25 (Crawled : 21:00) - globenewswire.com
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.71% C: -1.07%
ADXS | $0.54 12.48% 950 twitter stocktwits trandingview |
Health Technology
| | O: 1.01% H: 17.5% C: -15.0%

pharmaceuticals meeting results phase 2
Kronos Bio Reports Recent Business Progress and First-Quarter 2023 Financial Results
Published: 2023-05-10 (Crawled : 20:00) - globenewswire.com
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: 0.12% H: 0.77% C: 0.74%
SGEN | $228.74 0.1% 20M twitter stocktwits trandingview |
Health Technology
| | O: 0.29% H: 0.22% C: -0.53%
KRON | $0.9644 1.52% 1.49% 880K twitter stocktwits trandingview |
Health Technology
| | O: 1.66% H: 4.35% C: -4.35%

business financial results
Inhibrx Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-05-08 (Crawled : 20:00) - prnewswire.com
TSVT | $4.28 -7.56% -8.18% 470K twitter stocktwits trandingview |
| | O: -0.53% H: 2.31% C: 0.8%
BMY | $48.86 -0.27% -0.02% 16M twitter stocktwits trandingview |
Health Technology
| | O: -0.6% H: 0.54% C: 0.0%
INBX | $34.385 0.75% 0.74% 220K twitter stocktwits trandingview |
Health Technology
| | O: -2.76% H: 5.17% C: 2.29%
BLUE | $0.9274 -4.45% -4.66% 8.1M twitter stocktwits trandingview |
Health Technology
| | O: -3.22% H: 22.09% C: 16.39%

financial results
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.